细胞冷冻保存市场规模、份额和成长分析（按产品、应用、最终用途和地区）- 产业预测 2025-2032

2023 年细胞冷冻保存市场规模价值 88 亿美元，预计将从 2024 年的 107.8 亿美元成长到 2032 年的 546.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 22.5%。

细胞冷冻保存因其能够在极低的温度下保持细胞悬浮状态，有效地保持细胞活力并防止结晶形成而受到广泛欢迎。该技术对于保存用于基础研究和医学应用的生物材料（包括干细胞和活组织）至关重要。传统的冷冻方法常常因膜损伤或渗透压衝击而导致细胞死亡，因此冷冻保存对于长期储存至关重要。冷冻保护剂和温度控制技术的最新进展显着提高了冷冻保存的成功率。此外，对冷冻保存的细胞和组织进行广泛的品质测试可以评估它们是否适合移植，从而无需新鲜样本，并增加了研究和治疗的机会。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析

细胞冷冻保存市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 细胞冷冻培养基
  • 乙二醇
  • 二甲基亚砜
  • 甘油
  • 其他的
• 装置
  • 冷冻库
  • 培养箱
  • 液态氮供应罐
• 耗材
  • 低温管瓶
  • 低温管
  • 冷藏箱/容器
  • 其他的

细胞冷冻保存市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概况
• 干细胞
• 卵子和生殖细胞
• 精子细胞
• 肝细胞
• 其他的

细胞冷冻保存市场规模（依最终用途和复合年增长率） (2025-2032)

• 市场概况
• 生物製药和製药公司
• 研究组织
• 生物库
• 试管婴儿诊所
• 其他的

细胞冷冻保存市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Thermo Fisher Scientific（US）
• Merck KGaA（Germany）
• GE Healthcare（US）
• BioLife Solutions, Inc.（US）
• Cook Medical（US）
• FUJIFILM Irvine Scientific（US）
• Lonza（Switzerland）
• Sartorius AG（Germany）
• Cytiva（US）
• Corning Incorporated（US）
• STEMCELL Technologies Inc.（Canada）
• PromoCell GmbH（Germany）
• Bio-Techne Corporation（US）
• HiMedia Laboratories Pvt. Ltd.（India）
• Miltenyi Biotec（Germany）
• Takara Bio Inc.（Japan）
• ReproCELL Inc.（Japan）
• Core Dynamics, LLC（US）
• Chart Industries, Inc.（US）
• Worthington Industries（US）

结论和建议

Cell Cryopreservation Market size was valued at USD 8.8 billion in 2023 and is poised to grow from USD 10.78 billion in 2024 to USD 54.66 billion by 2032, growing at a CAGR of 22.5% during the forecast period (2025-2032).

Cell cryopreservation is gaining traction for its ability to maintain cells in a suspended state at cryogenic temperatures, effectively preserving their viability while preventing ice crystal formation. This technique is essential for preserving biological materials, including stem cells and viable tissues, used in both basic research and medical applications. Traditional freezing methods often lead to cell death due to membrane damage and osmotic shock, making cryopreservation vital for long-term storage. Recent advancements in cryoprotective agents and temperature control technologies have significantly improved the success rates of cryopreservation. Furthermore, extensive quality testing of cryopreserved cells and tissues allows for their suitability assessment for transplantation, eliminating the need for fresh samples and enhancing research and therapeutic opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Cryopreservation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Cryopreservation Market Segments Analysis

Global Cell Cryopreservation Market is segmented by Product, Application, End Use and region. Based on Product, the market is segmented into Cell Freezing Media, Equipment and Consumables. Based on Application, the market is segmented into Stem Cells, Oocytes and Embryotic cells, Sperm Cells, Hepatocytes and Others. Based on End Use, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, Research Institutes, Biobanks, IVF clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cell Cryopreservation Market

The global cell cryopreservation market is projected to experience significant growth driven by the escalating prevalence of chronic diseases and the emergence of novel viruses. This trend is further propelled by the heightened research and development efforts in stem cell science, as scientists and clinicians delve deeper into this field. Educational institutions worldwide are offering grants to PhD students, Clinical Research Fellows, and postdoctoral researchers, thereby fostering advancements in stem cell research. Additionally, various government initiatives aimed at promoting research activities within the pharmaceutical and biopharmaceutical sectors are also contributing to the market's expansion, highlighting the increasing importance of cell preservation technologies.

Restraints in the Cell Cryopreservation Market

The cell cryopreservation market faces significant restraints due to the presence of alternative therapies and the substantial costs associated with storage solutions. As various treatment options gain popularity, the demand for traditional cryopreservation methods may be impacted negatively. Additionally, the high expenses involved in maintaining and operating storage facilities for cryopreserved cells further hinder market growth. These financial burdens can deter new entrants and existing businesses from expanding their offerings, ultimately limiting the potential expansion of the cell cryopreservation market in the face of competing technologies and solutions that provide similar benefits at potentially reduced costs.

Market Trends of the Cell Cryopreservation Market

The cell cryopreservation market is increasingly favoring vitrification as a dominant preservation technique, driven by advancements in cryobiology and cell storage technologies. This method leverages fast freezing using high concentrations of cryoprotectants, significantly reducing ice formation and cellular damage compared to traditional slow cooling processes. While vitrification enhances cell viability and recovery rates, concerns about potential toxicity from concentrated cryoprotectants highlight the need for ongoing research and optimization. As the demand for cell-based therapies and regenerative medicine rises, the market is witnessing innovation and investment focused on improving vitrification techniques to enhance safety and efficacy in cryopreservation applications.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Cell Cryopreservation Market Size by Product & CAGR (2025-2032)

• Market Overview
• Cell Freezing Media
  • Ethylene Glycol
  • Dimethyl Sulfoxide
  • Glycerol
  • Others
• Equipment
  • Freezers
  • Incubators
  • Liquid Nitrogen Supply Tanks
• Consumables
  • Cryogenic vials
  • Cryogenic tubes
  • Cooler boxes/containers
  • Others

Global Cell Cryopreservation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Stem Cells
• Oocytes and Embryotic cells
• Sperm Cells
• Hepatocytes
• Others

Global Cell Cryopreservation Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Biopharmaceutical & Pharmaceutical Companies
• Research Institutes
• Biobanks
• IVF clinics
• Others

Global Cell Cryopreservation Market Size & CAGR (2025-2032)

• North America (Product, Application, End Use)
  • US
  • Canada
• Europe (Product, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLife Solutions, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Irvine Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytiva (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiMedia Laboratories Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReproCELL Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Core Dynamics, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chart Industries, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Worthington Industries (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations